Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống
1
/ 23 trang
THÔNG TIN TÀI LIỆU
Thông tin cơ bản
Định dạng
Số trang
23
Dung lượng
6,94 MB
Nội dung
NHÂN MỘT TRƯỜNG HỢP Viêm dày, nhiễm vi khuẩn Helicobacter pylori Bs Lê Đình Tín Phịng Khám Tiêu Hóa – Gan Mật Bàn luận Ngày 18/10/2012 Triệu chứng - Buồn nơn, nóng ruột, quặn bụng Xét nghiệm HP test IgG IgM: NEG - Đau thượng vị âm ỉ 24/8/2017 - Đã điều trị HP Bv ĐHYD, muốn kiểm tra Nhận định Không nhiễm HP Không nhiễm HP, khả năng: HP breath test: NEG -Nhiễm HP điều trị hết -Âm tính giả Nhiễm HP, khả năng: 24/12/2018 - Đau hơng phải, khó chịu vùng thượng vị HP breath test: POS -Tái phát hay Tái nhiễm -Dương tính giả (ít) False-negative results …There is firm evidence to implicate that recent use of proton pump inhibitors (PPI) (within weeks) or antimicrobials (within weeks) may lead to a decrease in the gastric bacterial load causing falsenegative results Bleeding can also reduce the sensitivity of both UBT and SAT Data from a systematic review suggests repeating diagnostic tests in patients with bleeding ulcer after at least weeks in case of a negative result In patients with precancerous conditions (e.g atrophic gastritis, intestinal metaplasia) or gastric cancer, as well as in patients with partial gastrectomy, diagnostic tests may have lower accuracy False-positive results …Apart from false-negative results listed above, UBT also gives false-positive results, which have received more attention during the past 10 years These false-positive results are typical to patients with acid-free stomach (due to AG or a long term use of PPIs), where urease-positive bacterial species or yeast-like organisms colonize http://www.mathewsopenaccess.com/PDF/Gastroenterology/M_J_Gast_1_1_007.pdf Bàn luận Successful eradication of H pylori is defined as negative H pylori status in a previously H pylori‐infected patient at least weeks after treatment Recurrence is defined as evidence of an active H pylori infection in a patient with previously confirmed H pylori eradication Recurrence can occur either by recrudescence or reinfection -Recrudescence is defined as reappearance of the original infection that was temporarily suppressed leading to false results tests regarding eradication -Reinfection is defined as infection with a new strain of H pylori or recurrence of infection after an as yet undefined period (eg, months to years) https://onlinelibrary.wiley.com/doi/full/10.1111/apt.14319#apt14319-bib-0015 Recrudescence reflects the reappearance of the originnal strain of H pylori following its temporary suppression rather than successful eradication Instead, true reinfection occurs when, after successful eradication, a patient becomes infected with either the original strain or a new strain of H pylori http://mattioli1885journals.com/index.php/actabiomedica/article/view/7947/7707 …Recurrence of H pylori after eradication is rare in developed countries and more frequent in developing countries The proportion of H pylori annual recurrence was 2.67% and 13.00% in developed and developing countries, respectively …A different approach for follow-up after H pylori eradication is probably needed in patients of developing countries, since reinfection is highly prevalent https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693738/ Aim: To evaluate the global recurrence rate following H pylori eradication therapy and confirm its association with socioeconomic and sanitary conditions Methods: A systematic search of PubMed, EMBASE and the Cochrane library was performed to identify potentially relevant publications using the following keywords: “Helicobacter pylori” or “H pylori” or “Hp” and “recurrence” or “recrudescence” or “reinfection” or “recurrent” or “recurred” or “re‐infect*” or “relapse*.” Results: A total of 132 studies (53 934 patient ‐years) were analysed -The global annual recurrence, reinfection and recrudescence rate of H pylori were 4.3% (95% CI, 4‐5), 3.1% (95% CI, 2‐5) and 2.2% (95% CI, ‐3), respectively -The H pylori recurrence rate was inversely related to the human development index (HDI) (ie, 3.1% [95% CI, 2‐4], 6.2% [95% CI, 4‐8] and 10.9% [95% CI, ‐18] in countries with a very high, high and medium or low HDI) (P